90 related articles for article (PubMed ID: 10683413)
1. Differential regional zif268 messenger RNA expression in an escalating dose/binge model of amphetamine-induced psychosis.
Shilling PD; Kelsoe JR; Kuczenski R; Segal DS
Neuroscience; 2000; 96(1):83-90. PubMed ID: 10683413
[TBL] [Abstract][Full Text] [Related]
2. Reduction of zif268 messenger RNA expression during prolonged withdrawal following "binge" cocaine self-administration in rats.
Mutschler NH; Miczek KA; Hammer RP
Neuroscience; 2000; 100(3):531-8. PubMed ID: 11098116
[TBL] [Abstract][Full Text] [Related]
3. Amphetamine-induced zif268 mRNA expression in the medial posterior nucleus accumbens in cholecystokinin-A receptor mutant rats.
Shilling PD; Feifel D; Kelsoe JR
Neurosci Lett; 2000 Mar; 281(1):17-20. PubMed ID: 10686405
[TBL] [Abstract][Full Text] [Related]
4. Brief social defeat stress: long lasting effects on cocaine taking during a binge and zif268 mRNA expression in the amygdala and prefrontal cortex.
Covington HE; Kikusui T; Goodhue J; Nikulina EM; Hammer RP; Miczek KA
Neuropsychopharmacology; 2005 Feb; 30(2):310-21. PubMed ID: 15496936
[TBL] [Abstract][Full Text] [Related]
5. Neonatal ventral hippocampus lesion leads to reductions in nerve growth factor inducible-B mRNA in the prefrontal cortex and increased amphetamine response in the nucleus accumbens and dorsal striatum.
Bhardwaj SK; Beaudry G; Quirion R; Levesque D; Srivastava LK
Neuroscience; 2003; 122(3):669-76. PubMed ID: 14622910
[TBL] [Abstract][Full Text] [Related]
6. Dynamic regulation of NGFI-A (zif268, egr1) gene expression in the striatum.
Moratalla R; Robertson HA; Graybiel AM
J Neurosci; 1992 Jul; 12(7):2609-22. PubMed ID: 1613551
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine.
Nguyen TV; Kosofsky BE; Birnbaum R; Cohen BM; Hyman SE
Proc Natl Acad Sci U S A; 1992 May; 89(10):4270-4. PubMed ID: 1374894
[TBL] [Abstract][Full Text] [Related]
8. Cocaine binges differentially alter striatal preprodynorphin and zif/268 mRNAs.
Daunais JB; McGinty JF
Brain Res Mol Brain Res; 1995 Apr; 29(2):201-10. PubMed ID: 7609608
[TBL] [Abstract][Full Text] [Related]
9. Decreased haloperidol-induced potentiation of zif268 mRNA expression in the nucleus accumbens shell and the dorsal lateral striatum of rats lacking cholecystokinin-A receptors.
Shilling PD; Feifel D
Synapse; 2002 Feb; 43(2):134-8. PubMed ID: 11754493
[TBL] [Abstract][Full Text] [Related]
10. A single injection of amphetamine or methamphetamine induces dynamic alterations in c-fos, zif/268 and preprodynorphin messenger RNA expression in rat forebrain.
Wang JQ; Smith AJ; McGinty JF
Neuroscience; 1995 Sep; 68(1):83-95. PubMed ID: 7477938
[TBL] [Abstract][Full Text] [Related]
11. Escalating dose-binge stimulant exposure: relationship between emergent behavioral profile and differential caudate-putamen and nucleus accumbens dopamine responses.
Segal DS; Kuczenski R
Psychopharmacology (Berl); 1999 Feb; 142(2):182-92. PubMed ID: 10102771
[TBL] [Abstract][Full Text] [Related]
12. Activation of metabotropic glutamate receptor mediates upregulation of transcription factor mRNA expression in rat striatum induced by acute administration of amphetamine.
Mao L; Wang JQ
Brain Res; 2002 Jan; 924(2):167-75. PubMed ID: 11750902
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of D1 and D2 dopamine receptor antagonists on acute amphetamine- or methamphetamine-induced up-regulation of zif/268 mRNA expression in rat forebrain.
Wang JQ; McGinty JF
J Neurochem; 1995 Dec; 65(6):2706-15. PubMed ID: 7595569
[TBL] [Abstract][Full Text] [Related]
14. Differences in the regional and cellular localization of c-fos messenger RNA induced by amphetamine, cocaine and caffeine in the rat.
Johansson B; Lindström K; Fredholm BB
Neuroscience; 1994 Apr; 59(4):837-49. PubMed ID: 7520134
[TBL] [Abstract][Full Text] [Related]
15. Expression of c-fos mRNA in the basal ganglia associated with contingent tolerance to amphetamine-induced hypophagia.
Bachand KD; Guthrie KM; Wolgin DL
Behav Brain Res; 2009 Mar; 198(2):388-96. PubMed ID: 19084559
[TBL] [Abstract][Full Text] [Related]
16. An escalating dose "binge" model of amphetamine psychosis: behavioral and neurochemical characteristics.
Segal DS; Kuczenski R
J Neurosci; 1997 Apr; 17(7):2551-66. PubMed ID: 9065515
[TBL] [Abstract][Full Text] [Related]
17. Escalating dose-binge treatment with methylphenidate: role of serotonin in the emergent behavioral profile.
Segal DS; Kuczenski R
J Pharmacol Exp Ther; 1999 Oct; 291(1):19-30. PubMed ID: 10490882
[TBL] [Abstract][Full Text] [Related]
18. Repeated binge exposures to amphetamine and methamphetamine: behavioral and neurochemical characterization.
Segal DS; Kuczenski R
J Pharmacol Exp Ther; 1997 Aug; 282(2):561-73. PubMed ID: 9262316
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of calmodulin content and calmodulin messenger RNA levels by acute and repeated, intermittent amphetamine in dopaminergic terminal and midbrain areas.
Michelhaugh SK; Gnegy ME
Neuroscience; 2000; 98(2):275-85. PubMed ID: 10854758
[TBL] [Abstract][Full Text] [Related]
20. Differentially altered mGluR1 and mGluR5 mRNA expression in rat caudate nucleus and nucleus accumbens in the development and expression of behavioral sensitization to repeated amphetamine administration.
Mao L; Wang JQ
Synapse; 2001 Sep; 41(3):230-40. PubMed ID: 11418936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
